General Info
Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.
Location: Woodlands
Country:
Industries:
Investment Regions: SEA
Investment Stages: late-stage, series-a
vc
SEA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Found a March 3, 2025 transaction where Hummingbird Bioscience licensed technology and was involved with Callio Therapeutics’ $187M Series A launch (Callio Therapeutics). That investment/corporate activity occurred less than 3 months before the reference date, so classify as very-active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Hummingbird Bioscience
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI